A detailed history of Wellington Management Group LLP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 314,554 shares of OCUL stock, worth $2.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
314,554
Previous 270,918 16.11%
Holding current value
$2.73 Million
Previous $2.47 Million 12.74%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.2 - $8.69 $183,271 - $379,196
43,636 Added 16.11%
314,554 $2.15 Million
Q1 2024

May 15, 2024

BUY
$3.85 - $10.93 $1.04 Million - $2.96 Million
270,918 New
270,918 $2.47 Million
Q3 2023

Nov 14, 2023

BUY
$3.14 - $5.04 $76,433 - $122,683
24,342 Added 8.67%
305,216 $958,000
Q2 2023

Aug 14, 2023

SELL
$4.6 - $7.64 $120,676 - $200,427
-26,234 Reduced 8.54%
280,874 $1.45 Million
Q1 2023

May 12, 2023

SELL
$2.79 - $6.27 $16,974 - $38,146
-6,084 Reduced 1.94%
307,108 $1.62 Million
Q4 2022

Feb 13, 2023

BUY
$2.61 - $4.41 $194,601 - $328,809
74,560 Added 31.24%
313,192 $880,000
Q3 2022

Nov 14, 2022

SELL
$4.09 - $6.5 $43,464 - $69,075
-10,627 Reduced 4.26%
238,632 $990,000
Q2 2022

Aug 15, 2022

BUY
$3.01 - $5.22 $1,538 - $2,667
511 Added 0.21%
249,259 $1 Million
Q1 2022

May 16, 2022

BUY
$4.83 - $7.35 $7,573 - $11,524
1,568 Added 0.63%
248,748 $1.23 Million
Q4 2021

Feb 11, 2022

BUY
$6.16 - $12.07 $1.52 Million - $2.98 Million
247,180 New
247,180 $1.72 Million
Q1 2020

May 14, 2020

SELL
$3.95 - $7.4 $571,833 - $1.07 Million
-144,768 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$2.57 - $4.73 $372,053 - $684,752
144,768 New
144,768 $572,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $668M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.